Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
FDA's union readies negotiations with HHS over some fired staff
Last month
Sandoz sues Amgen over nine-year launch delay for Enbrel biosimilar
Last month
Pharma
Law
Ironwood to look for alternative paths after FDA asks for another Phase 3
Last month
Pharma
Makary wants to replace animal testing with organoids. It may take a while
Last month
R&D
Bristol Myers' immunotherapy combo nets approvals in colorectal and liver cancer
Last month
R&D
CDMOs anticipate inspection bottlenecks after mass FDA firings
Last month
Manufacturing
FDA quietly begins reversing return-to-office mandate for some workers
Last month
Biotech CEOs to Cassidy: We're already seeing the effects of FDA's staff cuts
Last month
Pharma
Firings of HHS' probationary workers can proceed, appeals court says
Last month
Law
Drug pricing watchdog ICER offers ways to increase obesity drug access
Last month
Pharma
House panel mulls ways to boost struggling US biosimilar market
Last month
Law
Could Kennedy's FDA cuts trigger an obscure clawback provision for industry user fees?
Last month
Law
Rare disease hub at CDER and CBER faces new reality with staff crunch
Last month
Pharma
‘This is self-inflicted’: Leerink’s David Risinger on the market shock and hits to biopharma
Last month
People
RFK Jr. won’t testify before key Senate committee this week on HHS overhaul
Last month
Pharma
Trump administration leaves obesity coverage expansion out of new Medicare rule
Last month
Pharma
Marks was asked to provide non-existent vaccine risk data: WSJ
Last month
Novavax’s held-up approval package may signal warning for Covid vaccine makers
Last month
R&D
Pharma
Kennedy team defends Marks firing, while 20% of staff cuts may be 'mistakes'
Last month
Law
Senate confirms Dr. Oz to lead Medicare agency amid HHS overhaul
Last month
People
Pharma
FDA approves Amgen's Uplizna in IgG4-related disease
Last month
Pharma
Trump has touted Right to Try as a lifesaver. Several government staff supporting it were just let go
Last month
House and Senate committees call for briefings on health cuts from Kennedy
Last month
FDA will consolidate to five 'shared services offices,' according to memo to Hill staffers
Last month
Pharma
First page
Previous page
1
2
3
4
5
6
7
Next page
Last page